Devices, systems, and methods for combinatorial treatment of a condition with an implantable damping device and biologic therapeutic agent are disclosed herein. Methods for treating one or more effects of the condition, such as a neurological condition, include providing the implantable damping device and at least one other therapy, such as a biologic therapeutic agent, that treats the condition to the patient. The implantable damping device includes a flexible damping member and an abating substance and can be placed in apposition with a blood vessel. The flexible damping member forms a generally tubular structure having an inner and an outer surface, the inner surface formed of a sidewall having a partially deformable portion. The abating substance is disposed within the partially deformable portion and moves longitudinally and/or radially within the partially deformable portion in response to pulsatile blood flow.

The present disclosure relate to feed ingredients and formulated feed, methods for their manufacture, and uses thereof in nutritional applications such as in aquaculture, terrestrial animal feed, and human nutrition. The feed ingredient compositions comprise lysed microbial cells with a small aspect ratio and triglyceride oil.

The present disclosure relate to feed ingredients and formulated feed, methods for their manufacture, and uses thereof in nutritional applications such as in aquaculture, terrestrial animal feed, and human nutrition. The feed ingredient compositions comprise lysed microbial cells with a small aspect ratio and triglyceride oil.

The invention comprises an oral Omega-3-fatty acid-rich oil emulsion composition comprising DHA 50-100 mg/ml, made from all natural and biocompatible ingredients for use in management of treatment of a disorder to overcome the same. The composition may be a thixotropic emulsion in nanometric size range having better absorption, better stability at room temperature and refrigerated one (2-8° C.), either alone or in combination with vitamins, minerals, Generally Regarded As safe (GRAS) natural ingredients. in therapeutically effective amount. The disorders comprise pre-term birth disorder in pregnant women, cognitive disorders in children and cardiovascular disorders. The said emulsion is made by adding an oil phase comprising a natural emulsifier to an aqueous phase comprising a gum. Vitamin E TPGS, a preservative and a high intensity sweetener; under mechanical stirring. This invention also embodies a High Performance Liquid Chromatography (HPLC) method for assay of omega-3 fatty acids.

The invention comprises an oral Omega-3-fatty acid-rich oil emulsion composition comprising DHA 50-100 mg/ml, made from all natural and biocompatible ingredients for use in management of treatment of a disorder to overcome the same. The composition may be a thixotropic emulsion in nanometric size range having better absorption, better stability at room temperature and refrigerated one (2-8° C.), either alone or in combination with vitamins, minerals, Generally Regarded As safe (GRAS) natural ingredients. in therapeutically effective amount. The disorders comprise pre-term birth disorder in pregnant women, cognitive disorders in children and cardiovascular disorders. The said emulsion is made by adding an oil phase comprising a natural emulsifier to an aqueous phase comprising a gum. Vitamin E TPGS, a preservative and a high intensity sweetener; under mechanical stirring. This invention also embodies a High Performance Liquid Chromatography (HPLC) method for assay of omega-3 fatty acids.

Disclosed is a capsule including: an internal phase including at least one plant cell; and an external gel phase, that totally encapsulates the internal phase at its periphery, the external phase including at least one surfactant and at least one polyelectrolyte in the gel state.

Disclosed is a capsule including: an internal phase including at least one plant cell; and an external gel phase, that totally encapsulates the internal phase at its periphery, the external phase including at least one surfactant and at least one polyelectrolyte in the gel state.

A method for treating intact irritated or inflamed skin with a composition comprising at least one Histamine Receptor pathway inhibitor; at least one Lipoxygenase pathway inhibitor; at least one Cyclooxygenase pathway inhibitor and at least one Chemotaxis pathway inhibitor.

A method for treating intact irritated or inflamed skin with a composition comprising at least one Histamine Receptor pathway inhibitor; at least one Lipoxygenase pathway inhibitor; at least one Cyclooxygenase pathway inhibitor and at least one Chemotaxis pathway inhibitor.

The present invention encompasses methods of improving reproductive and respiratory health.